The Effect of Hyaluronidase on Depth of Necrosis in Hyaluronic Acid Filling-Related Skin Complications
Author:
- 18 May 2020
- journal article
- research article
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 44 (5) , 1778-1785
Abstract
Aim In this clinical study, 16 female patients with vascular compression and occlusion-related ischemia and skin necrosis after hyaluronic acid filling injection were analyzed retrospectively. Dose, timing, and efficacy of hyaluronidase use in skin necrosis are discussed. Patients and Methods In a total of 841 cases, aged between 18 and 60 years, hyaluronic acid filling injections were performed. All patients were followed up for 3–24 months. Filling injected areas include nasolabial (391 cases), lip (225 cases), glabella–forehead (90 cases), infraorbital (46 cases), malar region (25 cases), chin (24 cases), and nose (40 cases). Skin complications occurred in four cases during the application and in 12 cases 6–24 h after the procedure. Only palliative treatment was performed in six cases, while hyaluronidase was used in 10 cases in addition to palliative treatment. Hyaluronidase injection was performed 30 s after filling injection in four cases and 6–24 h after the injection in the remaining six cases. A total of 1500 units of hyaluronidase was applied to each case in average. Results Recovery period of the patients who received palliative treatment only lasted 40–60 days. The area of necrosis was limited in these patients who did heal well only with some change of pigmentation and no obvious scar. In the patient group who received hyaluronidase in addition to palliative treatment, a large necrosis area was observed at the same time in four patients. Despite the hyaluronidase treatment in this group, recovery period was 20–90 days. The affected and necrosis areas were large. The cause of ischemia depended both on occlusion and on compression. While four patients healed with a scar, the remaining 12 patients healed without any significant scar. Conclusions Hyaluronidase injection provides earlier recovery of limited skin necrosis. Immediate hyaluronidase injection allows small damage to heal in a short time; however, it does not completely eliminate large necrosis, although it limits the necrotic area. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.Keywords
This publication has 21 references indexed in Scilit:
- Severe vision loss caused by cosmetic filler augmentation: Case series with review of cause and therapyJournal of Cosmetic Dermatology, 2018
- Successfully Managing Impending Skin Necrosis following Hyaluronic Acid Filler Injection, using High-Dose Pulsed HyaluronidasePlastic and Reconstructive Surgery - Global Open, 2018
- Vascular Complications After Chin Augmentation Using Hyaluronic AcidAesthetic Plastic Surgery, 2017
- Reversible Alopecia with Localized Scalp Necrosis After Accidental Embolization of the Parietal Artery with Hyaluronic AcidAesthetic Plastic Surgery, 2017
- Filler migration to the forehead due to multiple filler injections in a patient addicted to cosmetic fillersJournal of Cosmetic and Laser Therapy, 2017
- Therapeutic Intra-arterial Hyaluronidase Infusion for Ophthalmic Artery Occlusion Following Cosmetic Facial Filler (Hyaluronic Acid) InjectionNeuro-Ophthalmology, 2014
- Nitroglycerin: A Review of Its Use in the Treatment of Vascular Occlusion After Soft Tissue AugmentationDermatologic Surgery, 2012
- The Risk of Alar Necrosis Associated with Dermal Filler InjectionDermatologic Surgery, 2009
- Avoidance of arterial occlusion from injection of soft tissue fillersAesthetic Surgery Journal, 2002
- Arterial embolization caused by injection of hyaluronic acid (RestylaneR)British Journal of Dermatology, 2002